CareFusion Signs Exclusive Distribution Agreement With Breas Medical

CareFusion Will Become Exclusive Distributor in the U.S. for Vivo Line of Ventilators

Feb 9, 2015

SAN DIEGO, CA, February 9, 2015 / PRNewswire / - CareFusion (NYSE:CFN), a leading global medical technology company, today announced it has signed an exclusive distribution agreement for the U.S. with Breas Medical for their Vivo line of ventilation equipment.

Under the terms of the agreement, CareFusion will be the exclusive U.S. distributor for the Vivo by Breas® line of life support and bi-level ventilators from Breas Medical, including the Vivo 50, Vivo 40 and Vivo 30. The Vivo product line is designed for home mechanical ventilation and complements CareFusion's other ventilator products such as the AVEA®, VELA®, 3100A and 3100B HFOV, Infant Flow® SiPAP, ReVel® and LTV® Series ventilators. The combination of CareFusion and Breas Medical ventilation solutions allows CareFusion to provide customers a complete range of ventilation products.

"CareFusion is committed to providing single-vendor solutions that enable care providers and health systems to partner with us to meet their patients' ventilation needs across the acuity continuum," said Kevin Ketzel, senior vice president and general manager of Respiratory Technologies for CareFusion. "Home ventilation is a critical need for many patients, and offering the Breas Medical Vivo line of home ventilators will provide additional choice for our customers. Breas Medical shares our commitment to innovation and high-quality products that help improve patients' lives."

Nicke Svanvik, CEO of Breas Medical added, "CareFusion is a great partner for the Breas Vivo brand. They have the scale, infrastructure, reputation, clinical experience and complementary product portfolio to make Breas's Vivo products a market leader in the United States. We are happy that CareFusion recognized the quality, robustness, innovation and design quality of our Vivo products."

The distribution agreement may be expanded with additional products and territories in the future. Financial terms of the agreement were not disclosed.

About BD

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. 

For more information on BD, please visit

About Breas Medical

Breas Medical is a leading manufacturer of innovative respiratory ventilators and sleep apnea products for the global home healthcare market. Breas and its affiliates offer a broad range of patient-focused respiratory devices including Vivo, Z1, Z1Auto, Nippy®, Clearway, and iSLEEP brands. Products are sold in over 40 countries. Breas Medical is a PBM Capital Group portfolio company and was acquired from GE Healthcare in February 2014. For more information, please visit

To view the original version on PR Newswire, visit:

CareFusion Corporation

Troy Kirkpatrick

858 617 2361
Email Troy

Back to News Releases

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.